Treating lung infections with better antibiotic decisions in Sri Lanka
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a new way of deciding when to use antibiotics helps patients with lower respiratory infections (like pneumonia or bronchitis) in Sri Lankan hospitals. If you were recently admitted with a new lung infection, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been admitted to the hospital within the last 48 hours.
- You must have a new respiratory illness (like cough, chest pain, or trouble breathing) that started less than 14 days ago.
- You need a sign of infection, such as fever, chills, or an abnormal white blood cell count.
- You or your parent/guardian must agree to participate, and follow-up at 30 days (by phone or visit) must be possible.
- You cannot have been hospitalized in the last 28 days, had surgery in the past week, or need a breathing machine or strong heart medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a lung ultrasound can help doctors decide if antibiotics are needed for children and teens hospitalized with a lower respiratory tract infection. It may reduce unnecessary antibiotic use.
This trial tests a tool to help doctors decide when antibiotics are truly needed for lung infections like bronchitis or pneumonia. It may help you avoid unnecessary antibiotics and their side effects.
This study looks at how doctors use a computer tool that gives decision support (like a smart assistant) when treating respiratory infections. The goal is to improve how such tools are designed for primary care settings.
This trial studies whether using the MeMed BV® blood test in the emergency room or urgent care can help doctors decide when antibiotics are (or are not) needed for suspected lung infections. It may help reduce unnecessary antibiotics while still treating infections when needed.
This trial tests whether an AI-powered stethoscope can help doctors decide when to use antibiotics for children with mild pneumonia. It aims to avoid unnecessary antibiotics while still treating those who need them.
This study tests whether quickly identifying the exact bacteria causing your lung infection and using special computer models to choose the best antibiotic dose can improve your recovery in the ICU. It aims to make antibiotic treatment more personalized and effective.
Hear when a new Lower Resp Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.